In Part 3 of Insight's dry eye series, academic and author Dr Maria Markoulli shares her interest in the impact...
Read moreIn Part 2 of Insight's dry eye series, independent optometrist Mr Leigh Plowman discusses how Google rankings of a dry...
Read moreIn Part 1 of Insight's dry eye series, Dr Laura Downie explains how an explosion in global investment in dry...
Read moreWhether it’s in the lab, within the clinic or even online, Australians are punching above their weight in dry eye...
Read moreDry eye remains a very common presentation to primary eyecare practitioners in Australia. Many experienced practitioners feel that the incidence...
Read moreMelbourne biopharmaceutical company Opthea has announced its inclusion on the ASX 300, just days after its lead drug candidate met...
Read moreA biopharmaceutical company that is developing cheaper anti-VEGF treatments for major global markets, including Australia, has reported positive results from...
Read moreFrom this month, surgeons can perform standalone minimally invasive glaucoma surgery (MIGS) under Medicare, seeing Australia become the first major...
Read moreResearchers have modified an off-the-shelf contact lens to correct a form of red–green colour blindness known as deuteranomaly, the most...
Read moreA safety review into Novartis’ new anti-VEGF drug Beovu has revealed that reported adverse events are consistent with the approved...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited